- Appearance:White Crystalline Powder
Anti-tumor agent isolated from the bark of the yew tree.Attached is a published reference from researchers who have used our paclitaxel product.Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFB pathway.Weekly paclitaxel has limited activity in esophageal cancer.
The median survival, modest activity, and tolerance of therapy indicate that weekly paclitaxel may be an option in patients unable to tolerate combination chemotherapy. .Paclitaxel Enhances TF Protein Expression and Surface Activity.Paclitaxel Enhances Thrombin-Induced Endothelial Tissue Factor Expression via c-Jun Terminal NH.
Isolated from Taxus brevifolia.
Not for human therapeutic use or for medicinal purposes. For research applications only.
|Handling||Warning.Toxic. May be Carcinogenic. Wear gloves/mask when handling product. Avoid contact by all means of exposure.|